https://aboutmusicschools.com https://slotmgc.com https://300thcombatengineersinwwii.com https://mobilephonesource.co.uk https://discord-servers.io https://esmark.net https://slotmgc.com https://nikeshoesinc.us https://ellisislandimmigrants.org https://holidaysanthology.com https://southaventownecenter.net https://jimgodfreydesign.com https://mckinneypaintingpros.com https://enchantedmansion.org https://mckinneypaintingpros.com https://laurabrodieauthor.com https://holidaysanthology.com https://ardictionary.com https://113.30.151.116 https://103.252.118.20 https://206.189.83.174 https://157.230.39.109 https://128.199.85.208 https://172.104.51.149 https://174.138.21.250 https://157.245.50.183 https://152.42.239.189 https://188.166.210.125 https://152.42.178.155 https://192.53.172.202 https://172.104.188.91 https://103.252.118.157 https://63.250.61.107 https://165.22.104.74

Karakteristik Demografi dan Klinikopatologi Pasien Kanker Paru di RSUD Al−Ihsan

Authors

  • Aida Fitriyane Hamdani Universitas Islam Bandung
  • Wida Purbaningsih Kedokteran, Universitas Islam Bandung
  • Widhy Yudistira Nalapraya Kedokteran, Universitas Islam Bandung

DOI:

https://doi.org/10.29313/jrk.v3i2.2959

Keywords:

Jenis Histopatologi, Kanker Paru, Staging

Abstract

Abstract. Based on the 2020 Global Burden of Cancer (GLOBOCAN), it is estimated that there are 2.2 million people in the world suffering from lung cancer with a percentage of 11.4% of all cancer-related incidents, with a mortality rate of 1.8 million, or 18% of the total cancer-related deaths. In 2020, the incidence of finding new cases of lung cancer in Indonesia reached 34,783 cases. Meanwhile, the death rate reached 30,843 people, which is in first place. Al-Ihsan Hospital is one of them as a Cancer center or hospital which is a referral center for West Java residents. This study aims to look at the demographic and clinicopathological characteristics of people with lung cancer at Al-Ihsan Hospital, West Java in 2020 and 2021. This study used a retrospective descriptive observational method with a sample size measured using total sampling. From this study it can be concluded that of the 82 patients who met the inclusion criteria, there were 49 patients in 2020 and 33 patients in 2021 with the highest age group, namely 55−64 years and dominated by men. It can also be concluded that the characteristics of lung cancer patients based on clinical symptoms are the most commonly found, namely patients with shortness of breath and chest pain. Based on the type of histopathology, the most common type is non-small cell lung carcinoma. Meanwhile, based on staging with an average staging, namely staging IV.

Abstrak.  Berdasarkan Global Burden of Cancer (GLOBOCAN) tahun 2020, diperkirakan terdapat 2,2 juta penduduk di dunia menderita kanker paru dengan persentase 11,4% dari semua insiden yang berhubungan dengan kanker, dengan tingkat kematian 1,8 juta, atau 18% dari jumlah kematian yang berhubungan dengan kanker. Tahun 2020, kejadian penemuan kasus baru kanker paru di Indonesia mencapai 34.783 kasus. Sementara itu, angka kematiannya mencapai 30.843 jiwa yang berada pada urutan pertama. RSUD Al-Ihsan salahsatunya sebagai Cancer centre atau rumah sakit yang menjadi pusat rujukan warga Jawa Barat. Penelitian ini bertujuan untuk melihat karakteristik demografi dan klinikopatologi pengidap kanker paru di RSUD Al-Ihsan Jawa Barat pada tahun 2020 dan 2021. Penelitian ini menggunakan metode observasional deskriptif retrospektif dengan besar sampel yang diukur penggunakan total sampling. Dari penelitian ini dapat disimpulkan bahwa dari 82 pasien yang memenuhi kriteria inklusi terdiri dari 49 pasien tahun 2020 dan 33 pasien tahun 2021 dengan kelompok usia tertinggi yaitu 55−64 tahun dan didominasi oleh laki-laki.  Dapat disimpulkan pula bahwa karakterisitik pasien kanker paru berdasarkan gejala klinis yang paling banyak ditemukan yaitu pasien dengan sesak nafas dan nyeri dada. Berdasarkan jenis histopatologi, jenis yang paling banyak adalah non small cell lung carcinoma.  Sedangkan, berdasarkan staging dengan rata-rata staging yaitu staging IV.

References

Sung H, Ferlay J, Siegel, Rebecca L. Laversanne, Mathieu Soerjomataram, Isabelle Jemal A, Freddie B. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence anda Mortality Worldwid for 36 Cancers in 185 Countries. 2021;71:209–49.

World Health Organization. International Agency for Research on Cancer in 2020. 2020;1–2.

Laurenzi GA, Turino GM, Fishman AP. Bullous disease of the lung. Vol. 32, The American Journal of Medicine. 2018. 361–378 p.

Dinas Kesehatan Kota Bandung. Profil Dinas Kesehatan Kota Bandung Tahun 2019. 2020;287.

Kemenkes. Kementerian Kesehatan Republik Indonesia. Kementeri Kesehat RI. 2019;1(1):1.

Komite Penanggulangan Kanker Nasional. Panduan Penatalaksanaan Kanker Paru. Kementeri Kesehat Republik Indones. 2019;1–47.

National G, Pillars H. Robbins Basic Pathology. 2018. 532–538 p.

PATEL AM, PETERS SG. Clinical Manifestations of Lung Cancer. Mayo Clin Proc. 2019 Mar 1;68(3):273–7.

Caballero Vázquez A, Romero Béjar JL, Albendín García L, Suleiman Martos N, Gómez Urquiza JL, Cañadas GR, et al. Risk factors for short-term lung cancer survival. J Clin Med. 2021;10(3):1–9.

National Comprehensive Cancer Network - NCCN. NCCN

Miller YE. Centennial Review Pathogenesis of Lung Cancer 100 Year Report.

National G, Pillars H. Disorders of the Respiratory Tract. 2006. 209 p.

Bmj L, Issn A, Neal RD. Lung cancer. 2019;1–11.

Chaft JE, Rimner A, Weder W, Azzoli CG, Kris MG, Cascone T. Lung cancer stages I–III non-metastatic non-small-cell lung cancer. Nat Rev Clin Oncol. 2021;18(9):547–57.

Omeati R. Review of Lung Cancer. Persada Husada Indones. 2017;1–9.

Agung IGBM, Saputra H, Mahendra IGAS, Sumadi D, Juli IW. Karakteristik Pasien Karsinoma Paru di RSUP Sanglah Denpasar Tahun 2017-2018. J Med Udayana. 2020;9(11):43–50.

Gebremariam TH, Haisch DA, Fernandes H, Huluka DK, Binegdie AB, Woldegeorgis MA, et al. Clinical Characteristics and Molecular Profiles of Lung Cancer. JTO Clin Res Reports. 2021;2(7):100196.

Farsad M. Staging of Lung Cancer. Curr Radiopharm. 2019;13(3):195–203.

Chaft JE, Rimner A, Weder W, Azzoli CG, Kris MG, Cascone T. Lung cancer stages I–III non-metastatic non-small-cell lung cancer. Nat Rev Clin Oncol. 2021;18(9):547–57.

Omeati R. Review of Lung Cancer. Persada Husada Indones. 2017;1–9.

Agung IGBM, Saputra H, Mahendra IGAS, Sumadi D, Juli IW. Karakteristik Pasien Karsinoma Paru di RSUP Sanglah Denpasar Tahun 2017-2018. J Med Udayana. 2020;9(11):43–50.

Gebremariam TH, Haisch DA, Fernandes H, Huluka DK, Binegdie AB, Woldegeorgis MA, et al. Clinical Characteristics and Molecular Profiles of Lung Cancer. JTO Clin Res Reports. 2021;2(7):100196.

Vavalà T, Catino A, Pizzutilo P, Longo V, Galetta D. Gender differences and immunotherapy outcome in advanced lung cancer. Int J Mol Sci. 2021;22(21)

Downloads

Published

2023-12-24